ArticleProbiotics and antimicrobial proteins2025
Antibacterial and Anti-virulence Properties of Cell-free Supernatant from a Mixture of Limosilactobacillus fermentum Strains Against Enterotoxigenic Escherichia coli.
Article in Probiotics and antimicrobial proteins, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
This study investigated the antimicrobial efficacy of a cell-free supernatant (CFS) and live cells from a mixture of Limosilactobacillus fermentum strains (139, 296, and 263). These strains are candidates for probiotic use and were evaluated against five STb virotype enterotoxigenic Escherichia coli (ETEC) strains. Antagonistic activities of L. fermentum mixed cells and CFS were assessed with the spot agar method. The impacts of CFS on viable cell counts in laboratory medium, biofilm formation, cell surface hydrophobicity, mucin, and motility were evaluated. The effects of CFS on ETEC viable cell counts under laboratory medium and during exposure to simulated gastrointestinal conditions were measured using plate count, and the physiological status of L. fermentum cells was assessed with flow cytometry. The nuclear magnetic resonance technique identified the metabolites from CFS and its effects on the ETEC metabolite profile. A larger growth inhibition zone was caused by L. fermentum viable cell mixture (18.4-35.8 mm) than CFS (10.1-30.1 mm). CFS caused viable cell count reductions of ≥ 5 log CFU/ml at 24 h of exposure and reduced biofilm formation, cell surface hydrophobicity, mucin, and swimming and swarming motility of ETEC strains. The exposure of ETEC strains to simulated gastrointestinal conditions resulted in viable cell counts < 2 log CFU/ml at the final digestion when supplemented with CFS. Exposure to CFS resulted in sizes of ETEC cell subpopulations characterized as dead or injured > 80.0%. Lactate and acetate were the most critical variables in CFS, directing decreased ETEC metabolic activity. Results showed that the examined CFS from L. fermentum 139, 263, and 296 mixture was an effective antimicrobial against ETEC.
Indexed as
Identifiers
40063223What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.